We are live on ! Find out more
GIM

Groesbeck Investment Management Portfolio holdings

AUM $62.8M
1-Year Est. Return 52.32%
This Fund
S&P 500
This Quarter Est. Return
+7.55%
1 Year Est. Return
+52.32%
3 Year Est. Return
+146.85%
5 Year Est. Return
+188.49%
10 Year Est. Return
+524.09%
AUM
$65.7M
AUM Growth
-$1.02M
Cap. Flow
-$4.79M
Cap. Flow %
-7.29%
Top 10 Hldgs %
34.57%
Holding
87
New
2
Increased
4
Reduced
43
Closed
4

Top Buys

Rank Stock Value
1
SWKS icon
Skyworks Solutions
SWKS
+$568K
2
NXST icon
Nexstar Media Group
NXST
+$374K
3
FAST icon
Fastenal
FAST
+$192K
4
FTNT icon
Fortinet
FTNT
+$184K
5
AAPL icon
Apple
AAPL
+$105K

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$1.21M
2
EVA
Enviva Inc.
EVA
+$282K
3
AVGO icon
Broadcom
AVGO
+$245K
4
CVS icon
CVS Health
CVS
+$244K
5
EW icon
Edwards Lifesciences
EW
+$223K

Sector Composition

Rank Sector Weight
1 Technology 31.23%
2 Healthcare 16.39%
3 Consumer Discretionary 14.61%
4 Industrials 13.43%
5 Financials 9.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AVGO icon
1
Broadcom
AVGO
$1.95T
$2.92M 4.45%
33,720
-3,430
-9% -$245K
LRCX icon
2
Lam Research
LRCX
$387B
$2.79M 4.25%
43,480
-1,930
-4% -$109K
AAPL icon
3
Apple
AAPL
$4.46T
$2.66M 4.05%
13,720
+600
+5% +$105K
MSFT icon
4
Microsoft
MSFT
$3.66T
$2.57M 3.92%
7,556
CDW icon
5
CDW
CDW
$19.1B
$2.46M 3.75%
13,426
-862
-6% -$151K
URI icon
6
United Rentals
URI
$70.5B
$2.37M 3.6%
5,310
TMO icon
7
Thermo Fisher Scientific
TMO
$209B
$1.91M 2.91%
3,662
UNH icon
8
UnitedHealth
UNH
$370B
$1.71M 2.61%
3,563
-297
-8% -$145K
ABBV icon
9
AbbVie
ABBV
$433B
$1.67M 2.54%
12,390
-8,229
-40% -$1.21M
TROW icon
10
T. Rowe Price
TROW
$24.2B
$1.64M 2.49%
14,604
-714
-5% -$78.2K
NXST icon
11
Nexstar Media Group
NXST
$5.92B
$1.61M 2.46%
9,700
+2,254
+30% +$374K
ODFL icon
12
Old Dominion Freight Line
ODFL
$44.5B
$1.6M 2.44%
8,684
-100
-1% -$16.2K
TSCO icon
13
Tractor Supply
TSCO
$17B
$1.54M 2.34%
34,750
THO icon
14
Thor Industries
THO
$4.04B
$1.49M 2.27%
14,430
-1,672
-10% -$141K
ORLY icon
15
O'Reilly Automotive
ORLY
$73.1B
$1.3M 1.98%
20,475
-75
-0.4% -$4.58K
FTNT icon
16
Fortinet
FTNT
$123B
$1.14M 1.74%
14,420
+2,700
+23% +$184K
GS icon
17
Goldman Sachs
GS
$311B
$1.14M 1.74%
3,535
-413
-10% -$136K
MDC
18
DELISTED
M.D.C. Holdings, Inc.
MDC
$1.1M 1.67%
23,493
-1,798
-7% -$74.9K
SSNC icon
19
SS&C Technologies
SSNC
$18.7B
$1.09M 1.67%
18,073
SHW icon
20
Sherwin-Williams
SHW
$87B
$1.07M 1.62%
4,015
CI icon
21
Cigna
CI
$72.2B
$1.03M 1.57%
3,678
V icon
22
Visa
V
$682B
$1.01M 1.54%
4,264
ESNT icon
23
Essent Group
ESNT
$6.15B
$991K 1.51%
21,180
FIVE icon
24
Five Below
FIVE
$12B
$978K 1.49%
4,975
ABT icon
25
Abbott
ABT
$182B
$916K 1.39%
8,400

Similar funds

Groesbeck Investment Management's Q2 2023 Portfolio in Review

As of Q2 2023, Groesbeck Investment Management held 87 positions worth $65.7M, down 1.5% from $66.7M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Groesbeck Investment Management withdrew a net $4.79M in Q2 2023, closing 4 positions and reducing 43 holdings. Its most notable exit was Enviva Inc., an estimated $282K position sold in full.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Groesbeck Investment Management opened a new position in Skyworks Solutions worth $596K.

  • Groesbeck Investment Management's largest Q2 2023 buy was Skyworks Solutions: 5,385 shares worth $596K.
  • Groesbeck Investment Management added most to Nexstar Media Group in Q2 2023, an estimated $374K increase.
  • Groesbeck Investment Management's biggest Q2 2023 reduction was AbbVie, cutting an estimated $1.21M.
  • Groesbeck Investment Management fully exited Enviva Inc. in Q2 2023, selling an estimated $282K.
  • Groesbeck Investment Management's ten largest holdings make up 35% of its $65.7M portfolio in Q2 2023.
  • Groesbeck Investment Management opened 2 new positions and closed 4 in Q2 2023.
  • Groesbeck Investment Management's portfolio value fell 1.5% quarter-over-quarter to $65.7M.

Based on Groesbeck Investment Management's 13F filing for Q2 2023, filed 26 Jul 2023.